RPRX Stock Earnings: Royalty Pharma Misses EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

RPRX stock results show that Royalty Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

The post RPRX Stock Earnings: Royalty Pharma Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.

• Legendary Investor Predicts: “Forget AI... THIS Technology Is the Future”